arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Alpha Cognition Inc.

ACOG
$8.18 ▼ -0.47 (-5.43%) at close
Healthcare ·Biological Products, (No Diagnostic Substances) ·USBiological Products, (No Diagnostic Substances)
18 Visible periods
25 Metrics
Peer-ranked Benchmarks
Price Chart
16
Health
Poor
Bearish
auto_awesome

Analytical Summary

Alpha Cognition Inc. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $178.1M
Dividend Yield —
Revenue Growth 267.6% ↗
Op. Margin -127.3% ↗
ROIC -11.6% ↘
FCF / Share $-0.32 ↗
Trailing P/E —
Price / Book 3.4x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

18-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$6.09M
↑ +267.6% —
Net Income Profit after all expenses
$-8.79M
↑ +16.2% —
Operating Margin Operating profit as % of sales
-127.3%
↑ +44.4% 0th
FCF / Share Free cash flow per share
$-0.32
↑ +41.1% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
1
Returns
22
Financial Health ↓
2
Cash Quality ↑
66

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 4 years · 18 quarters